In a study published this week in the New England Journal of Medicine, which was funded by the National Cancer Institute, Stand Up to Cancer and private philanthropy, identified mechanisms that enable advanced melanoma to become resistant to immunotherapies. Read article here….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.